Results 51 to 60 of about 108,867 (254)

Clostridium difficile Infection, Colorado and the Northwestern United States, 2007

Emerging Infectious Diseases, 2012
To determine the incidence of Clostridium difficile infection during 2007, we examined infection in adult inpatient and outpatient members of a managed-care organization. Incidence was 14.9 C. difficile infections per 10,000 patient-years.
Jennifer L. Kuntz, Eric S. Johnson, Marsha A. Raebel, Amanda F. Petrik, Xiuhai Yang, Micah L. Thorp, Steven J. Spindel, Nancy Neil, David H. Smith   +8 more
doaj   +1 more source

Clostridium difficile Infection [PDF]

Workplace Health & Safety, 2017
Preventing Clostridium difficile, the most common cause of health care–associated infections in hospitals and infectious disease death in the United States, is a national priority. Increased rates of infection among low-risk individuals in the community call for community-based prevention efforts to halt the increasing spread of this highly contagious ...
Jennan A, Phillips, Stephanie, Hammond
openaire   +2 more sources

Exosome‐mediated gut–brain axis signaling in neurodegenerative diseases: Mechanisms, experimental evidence, and therapeutic perspectives—A narrative review

Animal Models and Experimental Medicine, EarlyView.
The gut–brain axis is a bidirectional communication network between the intestines and brain, mediated by gut microbiota and exosomes, that regulates neuroinflammation, protein aggregation, and neuronal health processes central to neurodegenerative diseases.
Waheeb Sami Aggad, Rakesh Ghosh, Hailah M. Almohaimeed, Zuhair M. Mohammedsaleh, Fayez M. Saleh, Amany I. Almars, S. Renuka Jyothi, Rajashree Panigrahi, Ajoy Kumer, Bikram Dhara   +9 more
wiley   +1 more source

Surveillance of Clostridium difficile infection during the period 2008-2009 in Rho hospital

Microbiologia Medica, 2011
Clostridium difficile is a Gram positive bacillus, anaerobic, sporogenous, with oro-faecal transmission. The formation of the spores can persist in a long time, encouraging the transmission.
Cristina Rescaldani, Gabriella Candelieri, Marina Re, Roberto Ottaviano, Giovanna Miseferi   +4 more
doaj   +1 more source

Rewriting Tumor Immunity With Bacterial Membrane Vesicles: A Versatile and Potent Therapeutic Strategy

Advanced NanoBiomed Research, EarlyView.
Bacterial membrane vesicles (BMVs) emerge as promising platforms for cancer immunotherapy owing to their intrinsic adjuvant properties and tunable cargo delivery capabilities. Their ability to modulate the tumor microenvironment, enhance antitumor immune responses, and support personalized therapeutic strategies highlights their growing potential as ...
Md Sifat Rahi, Md Mijanur Rahman, Asma Talukder, Urooj Yousaf Virk, Jennifer C. Wilson, Nigel McMillan, Ming Q. Wei   +6 more
wiley   +1 more source

Reducing the Risk of Severe Complications among Patients with Clostridium difficile Infection

Canadian Journal of Gastroenterology, 2011
BACKGROUND: The incidence and severity of Clostridium difficile infections are increasing, and there is a need to optimize the prevention of complicated disease.
Kamran Manek, Victoria Williams, Sandra Callery, Nick Daneman   +3 more
doaj   +1 more source

Clostridium septicum sepsis and colorectal cancer - a reminder

World Journal of Surgical Oncology, 2009
Background Spontaneous clostridium septicum infections are rare and are associated with a high mortality. Association of clostridium infection with colorectal malignancies have been previously reported and most cases are described in tumours of the ...
McCloud Jonathon M, Mirza Nazzia N, Cheetham Mark J   +2 more
doaj   +1 more source

Clostridium species diversity in cattle

Ветеринария сегодня
Introduction. Clostridial infections, though relatively sporadic, are globally ubiquitous and specified by high mortality rates, resulting in substantial economic losses to agriculture.
P. N. Shastin, V. A. Savinov, A. I. Laishevtsev, E. D. Mandryka, E. A. Fabrikantova, A. V. Supova   +5 more
doaj   +1 more source

Clinical Risk Factors for Severe Clostridium difficile–associated Disease

Emerging Infectious Diseases, 2009
Identifying patients who are at high risk for severe Clostridium difficile–associated disease (CDAD) early in the course of their infection may help clinicians improve outcomes.
Timothy J. Henrich, Douglas Krakower, Asaf Bitton, Deborah S. Yokoe   +3 more
doaj   +1 more source

Probiotics in Clostridium difficile Infection [PDF]

Journal of Clinical Gastroenterology, 2011
Clostridium difficile infection (CDI) is one of the most prevalent nosocomial infections. A dramatic increase in the incidence and severity of CDI has been noted in the past decade. Current recommendations suggest metronidazole as first-line therapy in mild to moderately severe CDI and oral vancomycin in individuals with severe CDI, or when ...
Xi, Na, Ciaran, Kelly
openaire   +2 more sources